Lab to £30m+ in Revenue and a $310m Exit | Eric Mayes, CEO of Endomag

Eric Mayes, PhD, CEO of Endomag, shares his incredible journey from lab to market success. In this episode, hear how he led Endomag from a university spinout (UCL/University of Houston) to a $310 million acquisition, pioneering new methods for cancer detection. Eric reveals the tough calls, strategic pivots, and game-changing insights that drove Endomag’s growth. This episode is essential for medtech leaders and Deep Tech innovators looking to take big ideas to market.